Grown Rogue International (GRUSF) Consolidated Net Income (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Consolidated Net Income of -$2.2 million for Q1 2026, up 100.0% quarter-over-quarter from -$6493.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Consolidated Net Income (2009 - 2026) Analysis & Trends
Grown Rogue International's Consolidated Net Income history runs 18 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Consolidated Net Income changed N/A year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$3504.5 billion (down 72419474.33% YoY), while the FY2025 annual figure was -$2.1 million, changed N/A from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$2.2 million, up from -$6493.3 billion in the prior quarter.
- The five-year high for Consolidated Net Income was $2988.8 billion in Q3 2025, with the low at -$6493.3 billion in Q4 2025.
- The 5-year median for Consolidated Net Income is $135107.7 (2023), against an average of -$350.5 billion.
- The sharpest annual moves came in 2022 and 2025: Consolidated Net Income plunged 34.77% in 2022, then surged 2727625228.55% in 2025.
- Grown Rogue International's Consolidated Net Income stood at $638291.0 in 2022, then plunged by 333.55% to -$1.5 million in 2023, then jumped by 92.65% to -$109573.9 in 2024, then tumbled by 5925960021.93% to -$6493.3 billion in 2025, then soared by 100.0% to -$2.2 million in 2026.
- Business Quant data shows GRUSF's Consolidated Net Income at -$2.2 million in Q1 2026, -$6493.3 billion in Q4 2025, and $2988.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.48 Mn |
| Mar 31, 2026 | -2.21 Mn |
| Dec 31, 2025 | -6,493.31 Bn |
| Sep 30, 2025 | 2,988.77 Bn |
| Sep 30, 2024 | -109,573.89 |
| Jun 30, 2024 | -4.73 Mn |
| Oct 31, 2023 | -1.49 Mn |
| Jul 31, 2023 | 379,789.39 |
| Apr 30, 2023 | 851,897.00 |
| Jan 31, 2023 | 821,063.00 |
| Jan 31, 2022 | 638,291.00 |
| Jul 31, 2021 | 764,360.00 |
| Apr 30, 2021 | -586,589.00 |
| Jan 31, 2021 | 978,539.00 |
| Oct 31, 2020 | -610,383.00 |
| Jul 31, 2020 | -599,082.00 |
| Apr 30, 2020 | -617,681.00 |
| Jan 31, 2020 | -285,648.00 |
| Oct 31, 2019 | -465,242.00 |
| Jul 31, 2019 | -931,242.00 |